Compared to the controls, C-RAMP2-/- mice displayed impaired cardiac function, increased cardiac hypertrophy and fibrosis, and decreased survival, as early as on day 7 after TAC. The gene discussed is RAMP2; the disease is persistent truncus arteriosus.